Found: 4
Select item for more details and to access through your institution.
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/159632
- By:
- Publication type:
- Article
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/359071
- By:
- Publication type:
- Article
Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.
- Published in:
- Application of Clinical Genetics, 2010, v. 3, p. 41
- By:
- Publication type:
- Article